Mount Sinai Brooklyn-Breast Imaging
Our board-certified, fellowship-trained radiologists, surgeons, and oncologists work seamlessly as a team offering coordinated care to help ensure that patients who are diagnosed with breast cancer receive the most advanced care in a supportive atmosphere. The Breast Imaging Center and its providers are part of the Mount Sinai Health System and the Mount Sinai Tisch Cancer Center, which serves as a gateway for patients to research breakthroughs, the most advanced technologies, clinical trials, and new treatments. Our diagnostic imaging center upholds the highest standards, and has American College of Radiology accreditation.
Deep Expertise in Breast Imaging
Our breast cancer experts specialize in the diagnosis and treatment of breast cancer patients. We also have special expertise with high-risk patients, i.e., patients with genetic mutations, strong family history of breast and/or ovarian cancer, prior chest radiation at a young age, personal history of breast cancer or high-risk lesions, increased breast density, and race/ethnicity. In addition, we serve male patients and transgender patients who need screenings and/or diagnostic imaging in a safe environment.
Breast Cancer Screening Guidelines
Many patients want to know how often they should get a mammogram. The Society of Breast Imaging, the American College of Radiology, and the American Society of Breast Surgeons recommend that women whose risk is average should schedule an annual screening mammogram beginning at age 40, and continue annually as long as they are in good health.
We provide the following diagnostic imaging services:
- Screening Mammography With Three-Dimensional Tomosynthesis is an advanced digital technology that uses a low-dose X-ray system and computer reconstructions to create three-dimensional views of the breasts, which allows radiologists to see breast cancer before a lump can be felt—giving patients the best chance for a cure.
- Diagnostic Mammography (Tomosynthesis and Two-Dimensional Techniques) is an advanced digital technology used for patients with symptoms, such as a palpable mass or nipple discharge, or abnormalities detected in screening.
- Breast Ultrasound is a technology that uses sound waves that allows the radiologist to detect more cancers than mammography alone. Some patients, including women with dense breast tissue and high-risk patients, should receive supplemental screening with breast ultrasound if a magnetic resonance imaging (MRI) cannot be performed.
- Breast MRI produces clear, highly detailed digital images of breast tissue using magnets, radio waves, and computer reconstruction. Unlike X-rays, there is no radiation exposure. MRI is used to supplement mammography for high-risk groups of patients, such as those with genetic mutations, prior chest radiation at a young age, breast cancer prior to age 50 or history of breast cancer with dense breast tissue, patients undergoing neoadjuvant chemotherapy to assess treatment response, and patients with high-risk lesions and other risk factors. In addition, MRI is more accurate in detecting suspected silicone implant rupture.
- Positron Emissions Tomography (PET)/Computed Tomography (CT) Scans take three-dimensional images of the breasts to help evaluate if the cancer has spread to other organs in patients with a diagnosis of cancer.
- Breast Biopsy is a minimally invasive outpatient procedure performed with local anesthetic. The procedure extracts a small amount of tissue for diagnosing the specific type of breast cancer in order to tailor treatment and provide the best chance for a cure. Core biopsy procedures are the standard of care and do not cause cancer to spread. We perform the following types of core biopsy.
- Stereotactic Breast Biopsy: Uses mammogram images taken from different angles to guide the radiologist’s instruments
- Ultrasound-Guided Breast Biopsy: Uses ultrasound imaging to guide the radiologist's instruments
- MRI-Guided Breast Biopsy: Uses MRI images to guide the radiologist's instruments
- FNA (Fine Needle Aspiration): While core needle biopsy is the standard of care, FNA can be performed for those patients who cannot undergo a core biopsy, for symptomatic relief of a large cyst or abscess drainage
Once a tissue sample of the tumor is obtained, it is sent to the lab. Specialized pathologists analyze the tissue to determine whether a patient has breast cancer and, specifically, the type of cancer. Special techniques are employed to determine if the cancer is fed by estrogen, progesterone, the Her2-neu protein, or is not fed by any receptor (triple-negative breast cancer). This will help our surgeons and oncologists determine the best course of treatment for the breast cancer patient.
Multidisciplinary Breast Conferences
As part of the Mount Sinai Health System, patients with challenging diagnoses may have their cases reviewed at a weekly multidisciplinary breast conference. The attendees at this clinical conference include surgeons, radiologists, pathologists, oncologists, radiation oncologists, and other medical specialists from across the Mount Sinai Health System. This weekly conference allows patients to get the benefit of an entire system of cancer specialists to review their cases, resulting in optimal treatment recommendations.
Meet Our Team
At Mount Sinai Brooklyn, we pride ourselves in providing the most advanced imaging techniques and personal patient care in a calm, empathetic, and supportive environment.